牙买加：2025年公共卫生机构重要必需药品和医疗杂物清单（英文）

First Edition 1988Second Edition 1993Third Edition 1998Fourth Edition 2004Fifth Edition 2008Sixth Edition 2015Seventh Edition 2020Eighth Edition 2025 CONTENTS Preface................................................................................................... iInformation on Hospitals and Health Centres......................................... xExplanatory Notes................................................................................. xiPrescription Writing.............................................................................xivAlgorithm for Treatment of Hypertension............................................xviiAlgorithm for Management of Type 2 Diabetes...................................... aHydroxyurea Use in Sickle Cell Disease in the Primary Care Setting....... cSECTION 1.Cardiovascular System............................................................1SECTION 2.Central Nervous System..........................................................6SECTION 3.Drugs Used In Dermatology.................................................11SECTION 4.Ear, Nose & Oropharynx.......................................................14SECTION 5.Endocrine System.................................................................15SECTION 6.Gastro-Intestinal System.......................................................18SECTION 7.Treatment of Infections.........................................................20SECTION 8.Malignant Diseases and for Immunosuppression...................26SECTION 9.Musculoskeletal and Joint Diseases.......................................29SECTION 10.Drugs Affecting Nutrition and Blood.....................................31SECTION 11.Drugs used in Ophthalmology..............................................34SECTION 12.Drugs used in Genito-Urinary System Disorders....................36SECTION 13.Disorders of the Respiratory System......................................38SECTION 14.Vaccines and Related Products.............................................41SECTION 15.Drugs used in Anaesthesia....................................................42SECTION 16.Antidotes & Other Substances used in Poisoning..................45SECTION 17.Drugs used in Treatment Renal Disorders.............................46MEDICAL SUNDRIES........................................................................... 49DENTAL DEPARTMENT....................................................................... 56RADIOGRAPHY DEPARTMENT........................................................... 57RAW MATERIALS................................................................................ 58VEN List Formulary Request Form........................................................ 62PharmWatch: Drug Monitoring E-Reporting Form................................ 64Index to Chapter.................................................................................. 66 PREFACE Background The Vital, Essential, and Necessary List of Drugs andMedicalSundries(VEN List)was developed by theMinistry of Health, the first edition published in 1988.The primary purpose for the list is to guide procurementand management of drugs and medical sundries usedinthe public health sector.The List embraces theprinciple of Rational Drug use, which in its simplest form,characterizes rational procurement, rational prescribing,rational dispensing and rational use of drugs by patients.Doctors,nurses,pharmacists,and students of thesedisciplines in the public health institutions will find thelist useful and are encouraged to adhere to the List aspublished. The VEN List has undergone several reviews, on anaverage five yearly basis, since publication of the firstedition. The preceding edition was published in 2020.In carrying out this latest update a bold approach wasadopted to include therapies for conditions previouslyconsidered too expensive to treat, and therefore were notincluded in the VEN list. Additionally included, are newtherapies reflecting new technologies, which based onpresent scientific clinical evidence, will deliver optimumtherapeutic outcomes whilst at the same time being themost effective pharmacoeconomic options. As with earlier editions this VEN list is partially based onthe WHO Model List of Essential drugs that comprisesitems that should be readily available for use in publichealth institutions along with current national guidelinesfor specific conditions (such as HIV/AIDS, STIs, HTN, DM,Malignant Diseases, Asthma, TB/leprosy) which representthe best therapeutic intervention in each of the priorityconditions covered. The VEN List is a key policy and reference for the sector,and efforts are constantly made to ensure that it is updated,effectively disseminated and its regular and routine usepromoted. Use of the VEN List The VEN List2020,was prepared by an ad-hoc technicalworking group under the supervision of the NationalDrug and Therapeutics Committee (NDTC), following awell-managed process.It was the product of extensive,dilig